Larry L. Wei
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: September 06, 2024
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
Journal: Gastroenterology
Published: May 15, 2019
Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma.
Journal: Nature communications
Published: November 10, 2016
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma.
Journal: The Journal of clinical investigation
Published: August 23, 2016
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
Journal: Hepatology (Baltimore, Md.)
Published: January 05, 2016
NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 19, 2015
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: February 18, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026